Pacific Edge Limited (PFGTF)
OTCMKTS · Delayed Price · Currency is USD
0.0986
+0.0767 (350.23%)
At close: Jul 29, 2025
Pacific Edge Market Cap
Pacific Edge has a market cap or net worth of $112.92 million as of September 17, 2025. Its market cap has increased by 122.33% in one year.
Market Cap
112.92M
Enterprise Value
101.18M
Revenue
12.89M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.10
Market Cap Chart
Since October 30, 2003, Pacific Edge's market cap has increased from 1.94M to 112.92M, an increase of 5,734.37%. That is a compound annual growth rate of 20.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 17, 2025 | 112.92M | 98.66% |
| Dec 31, 2024 | 56.84M | -5.43% |
| Dec 29, 2023 | 60.11M | -76.60% |
| Dec 30, 2022 | 256.83M | -65.15% |
| Dec 31, 2021 | 736.90M | 15.59% |
| Dec 31, 2020 | 637.51M | 1,042.62% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 982.68M |
| Veradigm | 806.69M |
| Tian'an Technology Group | 792.01M |
| Elite Pharmaceuticals | 718.26M |
| Glass House Brands | 574.70M |
| CytoDyn | 377.06M |
| Northwest Biotherapeutics | 373.88M |
| American Oncology Network | 345.48M |